文献速递瓣膜外科

孤立性前叶脱垂行Alfieri修复或新腱索修复后结局的荟萃分析估计比较

Comparison of meta-analytical estimates of outcomes after Alfieri or neochordal repair in isolated anterior mitral prolapse.
PubMed 文献 · Eur J Cardiothorac Surg · 2023-01-01

该系统评价与荟萃分析纳入17项研究共1358例孤立性退行性前叶二尖瓣脱垂患者,比较Alfieri缘对缘修复与新腱索植入的耐久性。加权平均随访5.56±3.31年,Alfieri组再手术发生率率比新腱索组显著更低(9.40 vs 18.61/1000人年,P=0.04),随访中重度/重度二尖瓣反流复发率亦显著更低(10.68 vs 28.63/1000人年,P=0.01),两组手术结局与生存无差异。

要点

  • Alfieri修复再手术发生率率9.40/1000人年,显著低于新腱索修复的18.61/1000人年(P=0.04)。
  • Alfieri修复随访中重度/重度二尖瓣反流发生率率10.68/1000人年,显著低于新腱索修复的28.63/1000人年(P=0.01)。
  • 两组住院/30天再手术、死亡及随访死亡无差异;作者认为仍需进一步研究。

核心结论

  • 在孤立性退行性前叶二尖瓣病变中,Alfieri修复相比新腱索修复可能伴随更低的复发性二尖瓣反流发生率。
  • 作者指出这是首个此类荟萃分析,该领域仍需进一步研究。

研究设计与样本

  • 系统评价与荟萃分析,检索Ovid MEDLINE、Ovid Embase和The Cochrane Library。
  • 纳入17项研究共1358例患者,采用随机效应模型,并进行留一法、亚组分析(Alfieri vs 新腱索)和荟萃回归。

主要发现

  • 加权平均随访5.56±3.31年,全队列再手术发生率率为14.45/1000人年。
  • 亚组分析中Alfieri组再手术发生率率为9.40/1000人年,新腱索组为18.61/1000人年(P=0.04)。
  • 随访中重度/重度二尖瓣反流发生率率全队列为19.89/1000人年,Alfieri组为10.68/1000人年,新腱索组为28.63/1000人年(P=0.01)。
  • 在同质研究的敏感性分析中,Alfieri方法在反流复发方面仍具显著优势。
  • 手术结局或生存方面无差异;全队列中晚期再手术发生率增加与纽约心脏协会III/IV级及同期冠状动脉旁路移植术显著相关。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 作者指出这是首个此类荟萃分析,该领域仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Repair of the isolated degenerative anterior mitral leaflet has been considered more challenging and associated with compromised durability compared with isolated posterior leaflet in major series. Implantation of neochordae or Alfieri edge-to-edge is the most employed repair technique for isolated anterior repair currently, but little data exist comparing their relative durability. We sought to investigate this issue with this meta-analysis. METHODS: A literature search was performed (Ovid MEDLINE, Ovid Embase and The Cochrane Library). The primary outcome was the incidence rate (IR) of reoperation, the secondary outcomes were recurrent moderately severe/severe mitral regurgitation (MR), in-hospital/30-day reoperation and mortality and follow-up mortality. A random-effect model was used. Leave-one-out, subgroup analysis (Alfieri versus neochordae) and meta-regression were done. RESULTS: Seventeen studies (including 1358 patients) were included. At a weighted mean follow-up of 5.56 ± 3.31 years, the IR for reoperation was 14.45 event per 1000 person-year and significantly lower in Alfieri than neochordae repair (9.40 vs 18.61, P = 0.04) on subgroup analysis. The IR of follow-up moderately severe/severe MR was 19.89 event per 1000 person-year and significantly lower in Alfieri than neochordae repair (10.68 and 28.63, P = 0.01). In a sensitivity analysis comparing homogenous studies, a significant difference in the recurrence of regurgitation in favour of the Alfieri approach remained. There were no differences in operative outcomes or survival. There were significant associations between increased incidence of late reoperation and New York Heart Association class III/IV and associated coronary artery bypass graft procedure for whole cohort. CONCLUSIONS: Alfieri repair may be associated with a lower incidence of recurrent MR compared with neochordae-based repair in the setting of isolated degenerative anterior mitral pathology. This is the first such meta-analysis and further inquiry into this area is needed.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Khairallah S, Rahouma M, Dabsha A, et al. Comparison of meta-analytical estimates of outcomes after Alfieri or neochordal repair in isolated anterior mitral prolapse. Eur J Cardiothorac Surg. 2023. PMID: 36629477. doi:10.1093/ejcts/ezac587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。